FAK inhibitor or siRNA reduced OBCM- or WISP-1-increased cell migration and VCAM-1 expression in human PCa (Fig. 4C–H), indicating that WISP-1 enhanced FAK phosphorylation (Fig. 4B). Here, CCN4 is linked to posterior cortical atrophy.